Investors & Media

Events & Presentations

Events

  • 23/11/2022

    Company’s quarterly report for III quarter of 2022

  • 28/09/2022

    Company’s semi-annual report for I half of 2022

  • 18/05/2022

    Company’s quarterly report for I quarter of 2022

  • 15/03/2022

    Company’s annual report for 2021

  • 10/01/2022

    40th Annual J.P. Morgan Health Care Conference

  • 10/01/2022

    H.C. Wainwright Bioconnect Conference

  • 06/01/2022

    10th Annual LifeSci Partners Corporate Access Event

  • 11/12/2021

    63rd ASH Annual Meeting & Exposition

  • 07/12/2021

    44th Annual San Antonio Breast Cancer Symposium

  • 10/11/2021

    Company’s quarterly report for III quarter of 2021

  • 13/09/2021

    H.C. Wainwright 23rd Annual Global Investment Conference

  • 09/09/2021

    Morgan Stanley 19th Annual Global Healthcare Conference

  • 08/09/2021

    Company’s semi-annual report for I half of 2021

  • 10/08/2021

    12th Annual Wedbush PacGrow Healthcare Conference

  • 22/06/2021

    GPW Innovation

  • 11/06/2021

    Discussion On Ryvu Data Presented at EHA 2021 – Conference Call

  • 09/06/2021

    Synthetic lethality in cancer treatment – Ryvu Therapeutics seminar

  • 09/06/2021

    EHA2021 Virtual Congress

  • 04/06/2021

    ASCO Annual Meeting 2021

  • 26/05/2021

    STING & TLR-Targeting Therapies Digital Summit

  • 26/05/2021

    Erste Group Innovation Conference 2021

  • 25/05/2021

    UBS Global Healthcare Virtual Conference

    Live webcast

  • 12/05/2021

    Company’s quarterly report for I quarter of 2021

  • 16/03/2021

    Publication of the annual report for 2020

  • 19/11/2020

    Publication of Q3 2020 financial report

  • 15/09/2020

    Publication of H1 2020 financial report

  • 14/09/2020

    virtual

    H.C Wainwright & Co. – 22nd Annual Global Investment Conference

  • 10/06/2020

    Publication of Q1 2020 financial report

  • 16/04/2020

    live.ryvu.com

    Annual Financial Results 2019 video conference: Main Achievements in 2019 and Outlook for 2020 – 11.00 AM (CET) –

    live.ryvu.com

  • 09/04/2020

    Publication of Annual Report for 2019

    Report

  • 02/04/2020

    Solebury Trout Virtual Investor Conference

    Webcast

  • 23/03/2020

    Paris, France

    BIO Europe Spring 2020

  • 07/12/2019

    Orlando, FL, USA

    Ryvu Therapeutics at the 61st ASH Annual Meeting & Exposition

  • 07/12/2019

    Orlando, FL, USA

    61st ASH Annual Meeting & Exposition

  • 20/11/2019

    London, UK

    Jefferies London Healthcare Conference

  • 11/11/2019

    Hamburg, Germany

    Ryvu Therapeutics presents at BIO-Europe 2019

  • 06/11/2019

    Consolidated quarterly Q3 2019 report publication

    PDF

  • 06/11/2019

    National Harbor MD, USA

    34th Annual Meeting & Pre-Conference Programs (SITC 2019)

Presentations

Webinar

Poster presentations - EHA 2023:
June 2023

PDF

Webinar

ASH 2022 Conference:
December 2022

Webcast

Panel Discussion

European TAP Partners
Dream Big Make Bold Progress:
January 2023

YouTube

Webinar

Poster presentations - ENA 2022 :
October 2022

Webcast

Investor Call

Development Plans 2022-2024:
August 2022

Watch Webcast

Ryvu Therapeutics

Corporate Presentation: September 2023

PDF

Webinar

Key Opinion Leader Webinar
on RVU120: June 2022

Watch Webcast